Sanofi Consumer [SANOFICONR] vs Marksans Pharma [MARKSANS] Detailed Stock Comparison

Sanofi Consumer Healthcare Inc.

NSE
Loading...

Marksans Pharma Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanofi Consumer Healthcare Inc. wins in 12 metrics, Marksans Pharma Ltd. wins in 7 metrics, with 0 ties. Sanofi Consumer Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sanofi Consumer Healthcare Inc. Marksans Pharma Ltd. Better
P/E Ratio (TTM) 43.91 23.96 Marksans Pharma Ltd.
Price-to-Book Ratio 27.44 3.20 Marksans Pharma Ltd.
Debt-to-Equity Ratio 6.46 12.24 Sanofi Consumer Healthcare Inc.
PEG Ratio 34.17 2.91 Marksans Pharma Ltd.
EV/EBITDA 33.08 17.15 Marksans Pharma Ltd.
Profit Margin (TTM) 27.33% 12.85% Sanofi Consumer Healthcare Inc.
Operating Margin (TTM) 34.42% 18.08% Sanofi Consumer Healthcare Inc.
EBITDA Margin (TTM) 34.42% 18.08% Sanofi Consumer Healthcare Inc.
Return on Equity 73.09% 15.29% Sanofi Consumer Healthcare Inc.
Return on Assets (TTM) 37.99% 11.75% Sanofi Consumer Healthcare Inc.
Free Cash Flow (TTM) $1.67B $337.45M Sanofi Consumer Healthcare Inc.
Dividend Yield 1.08% 0.62% Sanofi Consumer Healthcare Inc.
1-Year Return -8.68% -2.65% Marksans Pharma Ltd.
Price-to-Sales Ratio (TTM) 12.01 3.07 Marksans Pharma Ltd.
Enterprise Value $102.22B $84.41B Sanofi Consumer Healthcare Inc.
EV/Revenue Ratio 11.64 3.01 Marksans Pharma Ltd.
Gross Profit Margin (TTM) 72.79% 58.08% Sanofi Consumer Healthcare Inc.
Revenue per Share (TTM) $381 $62 Sanofi Consumer Healthcare Inc.
Earnings per Share (Diluted) $104.19 $7.94 Sanofi Consumer Healthcare Inc.
Beta (Stock Volatility) N/A 1.03 N/A

Sanofi Consumer Healthcare Inc. vs Marksans Pharma Ltd. Stock Performance Analysis

Loading Price Chart...

SANOFICONR
MARKSANS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sanofi Consumer Healthcare Inc.2.24%0.01%-3.05%10.56%2.80%3.48%
Marksans Pharma Ltd.-1.03%5.80%20.40%51.59%31.03%38.86%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sanofi Consumer Healthcare Inc.-8.68%-5.84%-5.84%-5.84%-5.84%-5.84%
Marksans Pharma Ltd.-2.65%181.04%197.61%488.28%10,872.61%2,742.00%

Performance & Financial Health Analysis: Sanofi Consumer Healthcare Inc. vs Marksans Pharma Ltd.

MetricSANOFICONRMARKSANS
Market Information
Market Cap i₹105.86B₹86.20B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i5,2381,036,499
90 Day Avg. Volume i11,327832,265
Last Close₹4,720.10₹249.76
52 Week Range₹3,975.00 - ₹5,894.50₹155.00 - ₹266.60
% from 52W High-19.92%-6.32%
All-Time High₹5,894.50 (Jun 30, 2025)₹358.70 (Dec 02, 2024)
% from All-Time High-19.92%-30.37%
Growth Metrics
Quarterly Revenue Growth0.33%0.11%
Quarterly Earnings Growth0.50%0.08%
Financial Health
Profit Margin (TTM) i0.27%0.13%
Operating Margin (TTM) i0.34%0.18%
Return on Equity (TTM) i0.73%0.15%
Debt to Equity (MRQ) i6.4612.24
Cash & Liquidity
Book Value per Share (MRQ)₹166.71₹59.37
Cash per Share (MRQ)₹162.89₹14.74
Operating Cash Flow (TTM) i₹1.75B₹2.42B
Levered Free Cash Flow (TTM) i₹1.27B₹3.81B
Dividends
Last 12-Month Dividend Yield i1.08%0.62%
Last 12-Month Dividend i₹55.00₹1.40

Valuation & Enterprise Metrics Analysis: Sanofi Consumer Healthcare Inc. vs Marksans Pharma Ltd.

MetricSANOFICONR (Apr 24, 2026)MARKSANS (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i43.9123.96
Forward P/E i34.1717.29
PEG Ratio i34.172.91
Price to Sales (TTM) i12.013.07
Price to Book (MRQ) i27.443.20
Market Capitalization
Market Capitalization i₹105.86B₹86.20B
Enterprise Value i₹102.22B₹84.41B
Enterprise Value Metrics
Enterprise to Revenue i11.643.01
Enterprise to EBITDA i33.0817.15
Risk & Other Metrics
Beta iN/A1.03
Book Value per Share (MRQ) i₹166.71₹59.37

Financial Statements Comparison: Sanofi Consumer Healthcare Inc. vs Marksans Pharma Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSANOFICONR (2025)MARKSANS (2025)
Revenue/Sales i8.78B26.14B
Cost of Goods Sold i2.30B12.29B
COGS % of Revenue i26.2%47.0%
Gross Profit i6.48B13.85B
Gross Margin i73.8%53.0%
Research & Development iN/AN/A
Operating Income (EBIT) i2.97B4.56B
Operating Margin i33.8%17.4%
EBITDA i3.27B6.06B
EBITDA Margin i37.3%23.2%
Pre-Tax Income i3.20B5.04B
Pre-Tax Income % of Revenue i36.5%19.3%
Income Tax i802.00M1.21B
Income Tax % of Revenue i9.1%4.6%
Net Income (Profit) i2.40B3.83B
Profit Margin i27.3%14.6%

Balance Sheet & Liquidity Metrics

MetricSANOFICONR (2025)MARKSANS (2025)
Cash & Equivalents i3.75B4.96B
Total Current Assets i4.94B22.04B
Total Current Assets % of Revenue i56.3%84.3%
Total Current Liabilities i1.28B4.77B
Total Current Liabilities % of Revenue i14.6%18.3%
Long-Term Debt i171.00M2.63B
Long-Term Debt % of Revenue i1.9%10.1%
Total Shareholders Equity i3.84B24.89B
Retained Earnings iN/A14.22B
Retained Earnings % of Revenue i0.0%54.4%
Property, Plant & Equipment i351.00M185.74M

Cash Flow Statement Comparison

MetricSANOFICONR (2025)MARKSANS (2025)
Operating Cash Flow i2.38B2.42B
Operating Cash Flow % of Revenue i27.1%9.3%
Capital Expenditures i-76.00M-1.72B
Free Cash Flow i1.67B337.45M
FCF Margin i19.0%1.3%
Debt Repayment iN/A-60.06M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSANOFICONRMARKSANS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i23.03M453.16M
Float Shares i6.57M214.30M
% Held by Insiders i71.46%44.06%
% Held by Institutions i17.51%18.21%
% Held by Public i11.03%37.73%

Dividend Analysis & Yield Comparison: Sanofi Consumer Healthcare Inc. vs Marksans Pharma Ltd.

MetricSANOFICONRMARKSANS
Last 12-Month Dividend i₹55.00₹1.40
Last 12-Month Dividend Yield i1.08%0.62%
3-Year Avg Annual Dividend i₹18.33₹0.72
3-Year Avg Dividend Yield i1.11%0.40%
3-Year Total Dividends i₹55.00₹2.15
Ex-Dividend DateApr 17, 2025Aug 01, 2025